trans Palmitoleic acid ( t-16 :1 n-7 , or 16:1 t9 in the nomenclature usually applied to trans fatty acids and used herein ) arouses great scientific interest because it has been suggested to serve as a biomarker for lower risks of type 2 diabetes and coronary artery disease .